DelSiTech will be in attendance at AsiaTIDES 2020, on the 24-26th of February at the Westin Miyako Kyoto, Japan.

AsiaTIDES represents one of the many premier biopharmaceutical industry conventions in Japan, however is differentiated by a unique focus on oligonucleotide and peptide molecule development. Spanning from discovery, preclinical, clinical, and CMC extending to commercialization of innovative novel therapies. Furthermore, the event brings together world leaders in oligonucleotide and peptide molecule development in a setting promoting sharing of experiences, technologies and networking for partnering purposes.

Dr. Lasse Leino, CEO at DelSiTech, will be speaking at the event on the subject of “Long-acting Injectable Peptide Formulations Based on Biodegradable Silica”, as a result of our continued proactive development of Silica Matrix technologies within the oligonucleotide and peptide molecule delivery space. The talk will be held on the 25th of February at 5:00pm as a part of the “Peptide Discovery and Development” stream.

Would you be interested in meeting with us at AsiaTIDES 2020? Please do not hesitate to reach out here.

We look forward to meeting you in Kyoto!